Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atricure Inc
(NQ:
ATRC
)
26.21
+0.39 (+1.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Atricure Inc
< Previous
1
2
3
Next >
Navigating 6 Analyst Ratings For AtriCure
July 31, 2024
Via
Benzinga
ATRC Stock Earnings: AtriCure Meets EPS, Beats Revenue for Q2 2024
July 30, 2024
ATRC stock results show that AtriCure met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Analyst Ratings For AtriCure
July 08, 2024
Via
Benzinga
Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
June 28, 2024
Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 18, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For AtriCure
May 02, 2024
Via
Benzinga
Key Takeaways From AtriCure Analyst Ratings
April 10, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For AtriCure
February 16, 2024
Via
Benzinga
Recap: AtriCure Q4 Earnings
February 15, 2024
Via
Benzinga
ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024
May 01, 2024
ATRC stock results show that AtriCure missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Coinbase To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Friday
February 16, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Earnings Scheduled For February 15, 2024
February 15, 2024
Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
Via
Benzinga
AtriCure's Earnings: A Preview
February 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 18, 2024
Via
Benzinga
Key Takeaways From AtriCure Analyst Ratings
January 04, 2024
Via
Benzinga
Where AtriCure Stands With Analysts
November 29, 2023
Via
Benzinga
What 7 Analyst Ratings Have To Say About AtriCure
May 03, 2023
Via
Benzinga
Analyst Ratings for AtriCure
February 22, 2023
Via
Benzinga
Earnings Outlook For AtriCure
February 20, 2023
Via
Benzinga
New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
May 24, 2023
Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies’ (NASDAQ: BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in Ne
Via
Benzinga
Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
December 19, 2022
Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5. Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on...
Via
Benzinga
5 Analysts Have This to Say About AtriCure
August 03, 2022
Within the last quarter, AtriCure (NASDAQ:ATRC) has observed the following analyst ratings:
Via
Benzinga
AtriCure: Q2 Earnings Insights
August 02, 2022
AtriCure (NASDAQ:ATRC) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by...
Via
Benzinga
5 Analysts Have This to Say About AtriCure
July 18, 2022
Over the past 3 months, 5 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Analyst Ratings for AtriCure
June 28, 2022
Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
AtriCure's Q1 EPS Miss Estimates, Needham Lowers Price Target
May 04, 2022
Needham lowered AtriCure Inc's (NASDAQ: ATRC) price target to $67 from $79 due to peer multiple compression, with the Buy rating unchanged.
Via
Benzinga
4 Analysts Have This to Say About AtriCure
May 04, 2022
Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
AtriCure: Q1 Earnings Insights
May 03, 2022
AtriCure (NASDAQ:ATRC) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by...
Via
Benzinga
AtriCure Reports Deeper Losses In Q4 Despite 27% Jump In Sales, Issues FY22 Guidance
February 16, 2022
AtriCure Inc (NASDAQ: ATRC) reported Q4
Via
Benzinga
Recap: AtriCure Q4 Earnings
February 15, 2022
AtriCure (NASDAQ:ATRC) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.